ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 16 of 4737 for:    British | Canada

The Impact of Alternative Social Assistance Disbursement on Drug-related Harm (TASA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02457949
Recruitment Status : Recruiting
First Posted : May 29, 2015
Last Update Posted : May 14, 2018
Sponsor:
Collaborator:
British Columbia Centre for Excellence in HIV/AIDS
Information provided by (Responsible Party):
Lindsey Richardson, University of British Columbia

Brief Summary:
This study evaluates whether altering the timing and frequency of social assistance disbursement reduces drug related-harms that increase on the days surrounding monthly synchronized government social assistance cheque issue.

Condition or disease Intervention/treatment Phase
Drug Use Other: Non-synchronized social assistance receipt Other: cheque divided into two equal disbursements Not Applicable

Detailed Description:

Coordinated monthly income assistance payments, while seeking to alleviate poverty, can also have negative and unintended impacts, particularly among people who use illicit drugs (PWUD). Observational research has identified escalations in drug-related harm coinciding with monthly assistance payments, such as overdose, treatment interruption, hospital admissions and public disorder. This project varies the timing and frequency of income assistance disbursement, and evaluates whether varying income assistance disbursement reduces drug-related harm coinciding with coordinated income assistance.

Conducted among 273 PWUD, participants will be allocated for 6 income assistance cycles to a control or one of two intervention arms. Participants in the control arm will receive payments according to the existing monthly government schedule. Participants in the intervention arm will receive their income assistance: (1) monthly on a day different from government cheque issue; or (2) semi-monthly on days different from government cheque issue. The intervention will be evaluated using qualitative and quantitative methods for its impact on drug use and related harms.


Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 273 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Other
Official Title: The Impact of Alternative Social Assistance Disbursement on Drug-Related Harm: a Randomized Control Trial
Study Start Date : October 2015
Estimated Primary Completion Date : October 2018
Estimated Study Completion Date : October 2019

Arm Intervention/treatment
No Intervention: Treatment As Usual (TAU)
Receipt of social assistance on government cheque issue days for 6 income assistance cycles (approx 26 weeks).
Experimental: Staggered Arm
Receipt of social assistance once monthly on a randomly assigned day that does not fall during the week of government cheque issue (Non-synchronized social assistance receipt), for 6 income assistance cycles (approx 26 weeks).
Other: Non-synchronized social assistance receipt
Social assistance disbursement outside government cheque issue week
Other Name: Staggered

Experimental: Staggered and Split Arm
Receipt of social assistance twice monthly on equally spaced randomly assigned days that do not fall during the week of government cheque issue (Non-synchronized social assistance receipt, cheque divided into two equal disbursements), for 6 income assistance cycles (approx 26 weeks).
Other: Non-synchronized social assistance receipt
Social assistance disbursement outside government cheque issue week
Other Name: Staggered

Other: cheque divided into two equal disbursements
Social assistance disbursement divided into two equal payments
Other Name: Split




Primary Outcome Measures :
  1. Illicit drug use on government cheque issue days [ Time Frame: 26 weeks ]
    Timeline Follow Back (TLFB) assessed increase of drug use defined as an increase in the frequency of drug use of at least 40% or an increase in the number of drugs used during the 3 days beginning with government cheque issue day, compared to non-cheque issue days.


Secondary Outcome Measures :
  1. Illicit drug use on non-government cheque issue days [ Time Frame: 26 weeks ]
    Timeline Follow Back (TLFB) assessed increase of drug use defined as an increase in the frequency of drug use of at least 40% or an increase in the number of drugs used during the 3 days beginning with individual cheque issue day (among intervention participants), compared to non-cheque issue days.

  2. Hospital admissions on government cheque issue days [ Time Frame: 26 weeks ]
    Emergency Department, Emergency Department Mental Health and substance use hospitalizations in the three days beginning with government cheque issue day compared to non-cheque issue days.

  3. Overdose [ Time Frame: 26 weeks ]
    Self-reported non-fatal overdose and hospital record verified fatal overdose on the three days beginning with government cheque issue day compared to non-cheque issue days.

  4. Police service utilization [ Time Frame: 26 weeks ]
    Self-reported and police record-verified interactions with police or use of police services on the three days beginning with government cheque issue day compared to non-cheque issue days.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   19 Years to 64 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • be ≥19 years of age or older
  • reside in greater Vancouver, Canada
  • report regular use of illicit drugs other than cannabis
  • receive monthly provincial income assistance
  • are not currently administered (where cheque issue/money is externally managed)
  • be eligible and willing to be a client of the local credit union who will administer the intervention
  • report intensified drug use around government cheque issue days
  • provide written informed consent
  • be willing to comply with study procedures

Exclusion Criteria:

  • plan to relocate outside Vancouver
  • have plans to discontinue income assistance

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02457949


Contacts
Contact: Lindsey Richardson, DPhil 604-558-6677 lrichardson@cfenet.ubc.ca
Contact: Allison Laing 604-685-6355 ext 210 alaing@cfenet.ubc.ca

Locations
Canada, British Columbia
British Columbia Centre for Excellence in HIV/AIDS Recruiting
Vancouver, British Columbia, Canada, V6A 1H2
Contact: Allison Laing, BA    604-685-6355 ext 210    alaing@cfenet.ubc.ca   
Sponsors and Collaborators
University of British Columbia
British Columbia Centre for Excellence in HIV/AIDS
Investigators
Principal Investigator: Lindsey Richardson, DPhil University of British Columbia

Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Lindsey Richardson, Assistant Professor, University of British Columbia
ClinicalTrials.gov Identifier: NCT02457949     History of Changes
Other Study ID Numbers: H14-02401
First Posted: May 29, 2015    Key Record Dates
Last Update Posted: May 14, 2018
Last Verified: May 2018

Keywords provided by Lindsey Richardson, University of British Columbia:
Social Assistance
Drug Use
Drug-Related harm